Clinic
Roosevelt County Special Hospital District
Roosevelt County Special Hospital District was paid $27.72M by Medicaid between Jan 2018 and Dec 2024, across 105 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 90% of everything it billed.
33Billing provider infoROOSEVELT COUNTY SPECIAL HOSPITAL DISTRICT
PORTALES, NM 88130
PORTALES, NM 88130
33aNPI1316013402assigned 11/28/2006
33bProvider typeRural Health Clinic/Center
28Total paid$27.72M
24GClaims299,770
24DCodes billed105
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Rural Health Clinic/Center providers in New Mexico
Rank by total paid#1 of 11
Median peer was paid$2.62M
This provider vs. median11×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 20,843 | $2.88M | |
| 2019 | 21,440 | $2.91M | |
| 2020 | 14,595 | $2.88M | |
| 2021 | 53,445 | $4.23M | |
| 2022 | 74,524 | $5.44M | |
| 2023 | 63,015 | $4.85M | |
| 2024incomplete | 51,908 | $4.53M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 90% | 110,748 | 89,165 | $25.07M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.6% | 42,640 | 37,380 | $991K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.3% | 41,314 | 36,617 | $904K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 26,337 | 24,687 | $132K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 3,360 | 3,184 | $114K |
| G0511 | Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month | <1% | 3,885 | 3,847 | $90K |
| 81002 | <1% | 2,413 | 2,296 | $63K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 2,266 | 2,247 | $58K |
| 80305 | <1% | 1,847 | 1,725 | $37K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,553 | 1,529 | $29K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 4,379 | 4,221 | $26K |
| 96127 | <1% | 6,775 | 6,423 | $21K |
93 more codes
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,189 | $20K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 1,933 | $19K |
| 81025 | <1% | 784 | $16K | |
| 91300 | <1% | 96 | $16K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,712 | $13K |
| 87428 | <1% | 20,216 | $9K | |
| 91301 | <1% | 95 | $9K | |
| 20553 | <1% | 1,231 | $8K | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 1,283 | $6K |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 503 | $6K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 549 | $6K |
| 20610 | <1% | 303 | $5K | |
| 90686 | <1% | 224 | $5K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 203 | $3K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 559 | $3K |
| 2014F | <1% | 863 | $3K | |
| 99490 | Ccm add 20min | <1% | 115 | $3K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 17 | $3K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 521 | $2K |
| 86580 | <1% | 28 | $2K | |
| 90633 | <1% | 86 | $2K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 2,166 | $2K |
| 90656 | <1% | 58 | $2K | |
| 95886 | <1% | 12 | $2K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 2,912 | $2K |
| 90756 | <1% | 56 | $1K | |
| 90677 | <1% | 92 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 215 | $1K |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 833 | $1K |
| 90734 | <1% | 74 | $1K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 103 | $1K |
| 90651 | <1% | 90 | $883.36 | |
| 90696 | <1% | 33 | $790.23 | |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | <1% | 37 | $786.12 |
| 96160 | <1% | 69 | $735.28 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 98 | $600.83 |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 41 | $595.93 |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 1,686 | $588.14 |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 93 | $550.95 |
| 99205 | Prolong outpt/office vis | <1% | 84 | $535.98 |
| 99406 | <1% | 771 | $526.27 | |
| 3288F | <1% | 53 | $495.16 | |
| 95251 | <1% | 284 | $408.10 | |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | <1% | 12 | $384.01 |
| 99385 | <1% | 19 | $367.23 | |
| 87807 | <1% | 276 | $340.46 | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 131 | $307.80 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 358 | $289.47 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 471 | $279.12 |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 83 | $256.66 |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 15 | $208.89 |
| 0011A | <1% | 121 | $207.95 | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 409 | $203.14 |
| 0012A | <1% | 111 | $195.88 | |
| 90715 | <1% | 53 | $164.13 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 12 | $106.25 |
| 90694 | <1% | 17 | $104.82 | |
| 90661 | <1% | 13 | $91.67 | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 46 | $82.82 |
| 90710 | <1% | 15 | $78.89 | |
| 4450F | <1% | 20 | $29.20 | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 19 | $14.90 |
| 20552 | <1% | 13 | $11.75 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 27 | $8.45 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 25 | $7.42 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 89 | $2.57 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 13 | $0.15 |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 325 | $0.00 |
| 90461 | 0% | 1,109 | $0.00 | |
| 99442 | 0% | 14 | $0.00 | |
| 3725F | 0% | 58 | $0.00 | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 0% | 526 | $0.00 |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 0% | 172 | $0.00 |
| 0002A | 0% | 290 | $0.00 | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 0% | 212 | $0.00 |
| 90671 | 0% | 94 | $0.00 | |
| 0003A | 0% | 56 | $0.00 | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 0% | 90 | $0.00 |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 0% | 19 | $0.00 |
| 86756 | 0% | 97 | $0.00 | |
| 0013A | 0% | 33 | $0.00 | |
| G9509 | Adult patients 18 years of age or older with major depression or dysthymia who reached remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5 | 0% | 98 | $0.00 |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 0% | 17 | $0.00 |
| 0071A | 0% | 13 | $0.00 | |
| 90670 | 0% | 13 | $0.00 | |
| 0001A | 0% | 202 | $0.00 | |
| G0009 | Administration of pneumococcal vaccine | 0% | 79 | $0.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 896 | $0.00 |
| G9717 | Documentation stating the patient has had a diagnosis of bipolar disorder | 0% | 13 | $0.00 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 0% | 13 | $0.00 |
| J3480 | Injection, potassium chloride, per 2 meq | 0% | 13 | $0.00 |
| 96361 | Intravenous infusion, hydration; each additional hour | 0% | 18 | $0.00 |
| 1101F | 0% | 45 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLEARNING, LORENCE (CEO)